177 related articles for article (PubMed ID: 36418188)
21. Epstein-Barr Virus Regulates Endothelin-1 Expression through the ERK/FOXO1 Pathway in EBV-Associated Gastric Cancer.
Liu W; Zhang Q; Zhang Y; Sun L; Xiao H; Luo B
Microbiol Spectr; 2023 Feb; 11(1):e0089822. PubMed ID: 36475746
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus miR-BART4-3p regulates cell proliferation, apoptosis, and migration by targeting AXL in gastric carcinoma.
Zhao MH; Liu W; Zhang Y; Liu JJ; Song H; Luo B
Virus Genes; 2022 Feb; 58(1):23-34. PubMed ID: 35083633
[TBL] [Abstract][Full Text] [Related]
24. Association of single nucleotide polymorphism rs2065955 of the filaggrin gene with susceptibility to Epstein-Barr virus-associated gastric carcinoma and EBV-negative gastric carcinoma.
Kuang X; Sun L; Liu S; Zhao Z; Zhao D; Liu S; Luo B
Virol Sin; 2016 Aug; 31(4):306-13. PubMed ID: 27535066
[TBL] [Abstract][Full Text] [Related]
25. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
[TBL] [Abstract][Full Text] [Related]
26. Latent membrane protein 2A inhibits expression level of Smad2 through regulating miR-155-5p in EBV-associated gastric cancer cell lines.
Shi Q; Zhang Y; Liu W; Xiao H; Qi Y; Li J; Luo B
J Med Virol; 2020 Jan; 92(1):96-106. PubMed ID: 31469179
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.
Wang J; Zheng X; Qin Z; Wei L; Lu Y; Peng Q; Gao Y; Zhang X; Zhang X; Li Z; Fu Y; Liu P; Liu C; Yan Q; Xiong W; Li G; Lu J; Ma J
J Biol Chem; 2019 Mar; 294(13):4854-4866. PubMed ID: 30674552
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting E2F3.
Park MC; Kim H; Choi H; Chang MS; Lee SK
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681596
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
Yang J; Liu Z; Zeng B; Hu G; Gan R
Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
[TBL] [Abstract][Full Text] [Related]
30. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
32. Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Hematol Oncol; 2017 Dec; 35(4):655-663. PubMed ID: 27709652
[TBL] [Abstract][Full Text] [Related]
33. ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3.
Zhang JY; Du Y; Gong LP; Shao YT; Pan LJ; Feng ZY; Pan YH; Huang JT; Wen JY; Sun LP; Chen GF; Chen JN; Shao CK
Cancer Lett; 2022 Jun; 535():215646. PubMed ID: 35304258
[TBL] [Abstract][Full Text] [Related]
34. The Epstein-Barr virus-miRNA-BART6-5p regulates TGF-β/SMAD4 pathway to induce glycolysis and enhance proliferation and metastasis of gastric cancer cells.
Zhao X; Huang X; Dang C; Wang X; Qi Y; Li H
Oncol Res; 2024; 32(5):999-1009. PubMed ID: 38686046
[TBL] [Abstract][Full Text] [Related]
35. Expression of MAP9 in Epstein-Barr virus-associated gastric carcinoma.
Xiao H; Sun J; Huang W; Liu W; Zhang Y; Wang H; Luo B
Virus Res; 2021 Feb; 293():198253. PubMed ID: 33309912
[TBL] [Abstract][Full Text] [Related]
36. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma.
Zhang J; Huang T; Zhou Y; Cheng ASL; Yu J; To KF; Kang W
J Cell Mol Med; 2018 Jan; 22(1):38-45. PubMed ID: 28990284
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of Epstein-Barr virus DNA in plasma and stomach biopsies of patients with gastric cancer.
Sarshari B; Ravanshad M; Rabbani A; Zareh-Khoshchehreh R; Mokhtari F; Khanabadi B; Mohebbi SR; Asadzadeh Aghdaei H
Virus Genes; 2023 Jun; 59(3):351-358. PubMed ID: 36757510
[TBL] [Abstract][Full Text] [Related]
38. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
39. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1.
Wang J; Ge J; Wang Y; Xiong F; Guo J; Jiang X; Zhang L; Deng X; Gong Z; Zhang S; Yan Q; He Y; Li X; Shi L; Guo C; Wang F; Li Z; Zhou M; Xiang B; Li Y; Xiong W; Zeng Z
Nat Commun; 2022 Feb; 13(1):866. PubMed ID: 35165282
[TBL] [Abstract][Full Text] [Related]
40. CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC.
Wang W; Zhang Y; Liu W; Zhang X; Xiao H; Zhao M; Luo B
Theranostics; 2020; 10(25):11549-11561. PubMed ID: 33052232
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
